Why the study?
Do oral contraceptives increase the incidence of superficial and deep-vein thromboembolic disease in women of childbearing age?
Do oral contraceptives increase the incidence of superficial and deep-vein thromboembolic disease in women of childbearing age?
This review concludes that oral contraceptive use does not increase the risk of superficial and deep-vein thromboembolic disease in women of childbearing age.
Answers are grounded in this paper and cite their sources.
Supports no increased thromboembolic risk with oral contraceptives; leaves open need for contemporary randomized confirmation.
The average normal incidence of superficial and deep-vein thromboembolic disease in women of childbearing age is 2.2 cases per 1,000 women per year. The incidence of this disease is not increased during pregnancy, when estrogen secretion is increased, or when oral contraceptives are employed. In over 80,000 women receiving oral contraceptives for more than 1,000,000 cycles the incidence of superficial and deep-vein thromboembolic disease is 0.97 cases per 1,000 women per year. Retrospective survey studies have provided the hypothesis of increased risk in women taking oral contraceptives, but this hypothesis is not confirmed by the large volume of prospective data. Available data do not demonstrate that women with a history of thromboembolic disease are more susceptible to a recurrence when using oral contraceptives, and women developing thrombophlebitis have recovered uneventfully while continuing to use oral contraceptives.
No takes yet. Share an insight, caveat, or question.
Victor A. Drill (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: